Quotient Clinical is delighted to receive a BVCA Management Team Award in the category of “Large Company”. The Award was presented to CEO Mark Egerton and CFO Gordon Cameron at last night’s annual BVCA Midlands Dinner in Birmingham.
Now in its eighth year, the BVCA Management Team Awards recognise and reward the achievements and success of businesses across the UK which are backed by private equity and venture capital funds.
The judges commented:
“The Quotient team under Mark Egerton are building a very exciting drug development and pharma services business, recognised in their sector by customers and competitors for developing a unique Translational Pharmaceutics® solution others are unable to match. We admire their courage in investing heavily in this new approach and recognise the rewards they are achieving through rapid growth.”
All of the winners will now be entered into the national final to compete against other UK regions before the national winners are announced at the BVCA Gala Dinner on 8 December in London.